* Two potential blockbuster drugs - BNC210 and BNC105 * BNC105 - solid tumour cancer treatment which works by shutting down blood vessels in tumours * BNC210 - a next generation compound under development for anxiety and depression * Kv1.3, which has been partnered with global biotech Merck Serono, for the treatment of Multiple Sclerosis * Additional pipeline of early stage compounds